D-1125-2017 Class II Terminated

Recalled by Morton Grove Pharmaceuticals, Inc. — Morton Grove, IL

FDA drug recall D-1125-2017 was initiated by Morton Grove Pharmaceuticals, Inc. on Aug 10, 2017 and is designated Class II. Reason for recall: Presence of Foreign Substance: customer complaint of blue foreign material identified as a portion of a nitrile glove was discovered in product. The recall status is terminated (terminated Sep 13, 2018). Affected quantity: 7332 bottles.

Recall details

Product Type
Drugs
Report Date
Sep 6, 2017
Initiation Date
Aug 10, 2017
Termination Date
Sep 13, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
7332 bottles

Product description

Amoxicillin and Clavulanate Potassium for Oral Suspension, USP, 250/62.5 mg per 5 mL, 100 mL (when reconstituted) bottle, Rx Only, Manufactured By: Cipla Ltd. at Medispray Laboratories Pvt. Ltd., Kundaim Goa, India; Manufactured For: Wockhardt USA, LLC, Parsippany, NJ 07054, NDC 60432-065-00.

Reason for recall

Presence of Foreign Substance: customer complaint of blue foreign material identified as a portion of a nitrile glove was discovered in product.

Distribution pattern

Nationwide in the USA and Puerto Rico.

Code information

Batch #: KH60276, Exp 10/18

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1125-2017
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1125-2017. Report a data issue: hello@regdatalab.com.